ArticleFrontiers in pharmacology2025

Dipeptidyl peptidase-4 enzyme inhibition and its impacts on hepatic preneoplasia: a new avenue for liver cancer management.

Hebatollah E Eitah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.